Topical application of interferon inducers
AssigneeMerck & Co., Inc.
InventorsArthur K. Field, Richard J. Harwood
Life of this patent
Estimating the term…
Abstract
Virus infections of eye, skin and mucous membrane tissue are effectively treated by controlled release topical application of interferon inducers.
Claims8
An improved method of treating virus infections of skin, eye and mucous membrane tissue susceptible to treatment with interferon by topically applying a therapeutically effective antiviral amount of an interferon inducer selected from the group consisting of synthetic double-stranded RNA, a natural double-stranded RNA, and a nonpolynucleotide, the improvement consisting of incorporating said interferon inducer and a water soluble polymer selected from the group consisting of cellulose ethers, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinylpolymer and polyethylene glycol.
An improved composition for the treatment of virus infections of skin, eye and mucous membrane tissue susceptible to treatment with interferon comprising a therapeutically effective antiviral amount of an interferon inducer selected from the group consisting of synthetic double-stranded RNA, natural double-stranded RNA, and a nonpolynucleotide, the improvement consisting of incorporating said interferon inducer in a homogeneous mixture of said interferon inducer and a water soluble polymer selected from the group consisting of cellulose ethers, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinylpolymer and polyethylene glycol.
Dependencies are inferred from the claim text.